tiprankstipranks
Advertisement
Advertisement

Oscar Health Projects 2026 Growth Despite 2025 Loss

Story Highlights
  • Oscar Health secured a $475 million revolving credit line to enhance liquidity and support general corporate growth.
  • Oscar Health grew 2025 revenue and membership but incurred large losses, while guiding to higher 2026 revenue and profitability.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Oscar Health Projects 2026 Growth Despite 2025 Loss

Claim 55% Off TipRanks

An update from Oscar Health ( (OSCR) ) is now available.

Oscar Health entered into a $475 million secured revolving credit facility on February 6, 2026, providing three-year funding capacity, expandable by an additional $100 million, to support general corporate purposes and bolster liquidity. The facility, backed by guarantees from its subsidiaries and subject to leverage, coverage, premium and liquidity covenants, strengthens the company’s financial flexibility as it manages growth and risk in the competitive health insurance market.

Separately, on February 10, 2026, Oscar reported full-year 2025 revenue of about $11.7 billion, up from $9.2 billion in 2024, on the back of record membership of roughly 3.4 million but swung to a $396.4 million operating loss as higher market morbidity and utilization drove its medical loss ratio to 87.4%. The insurer ended 2025 with 2.0 million individual and small group members, discontinued its Cigna+Oscar small-group partnership, and issued 2026 guidance calling for $18.7–$19.0 billion in revenue and improved profitability, signaling a reset year aimed at returning to positive earnings.

The most recent analyst rating on (OSCR) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.

Spark’s Take on OSCR Stock

According to Spark, TipRanks’ AI Analyst, OSCR is a Neutral.

The score is primarily held back by weak financial performance—ongoing losses and deteriorating free cash flow—along with a bearish technical setup (below key moving averages and negative MACD). The earnings call adds modest support due to strong growth and reaffirmed guidance, but rising medical costs (higher MLR) and continued losses keep risk elevated, while valuation is constrained by a negative P/E and no dividend yield.

To see Spark’s full report on OSCR stock, click here.

More about Oscar Health

Oscar Health, Inc. is a U.S. health insurance company focused on the individual and small group markets, offering affordable, technology-enabled health plans. The New York-based insurer emphasizes digital tools, including AI-driven features, to improve member experience and drive growth across consumer and employer segments.

Average Trading Volume: 9,997,356

Technical Sentiment Signal: Sell

Current Market Cap: $3.24B

For detailed information about OSCR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1